** Insurance company MetLife MET.N reported higher Q3 profit on Wednesday, driven by increased investment income
MARGINS ON THE MEND
** J.P. Morgan ("overweight," PT: $93) expects co to deliver steady performance in its retirement business and continued growth in international sales
** Morgan Stanley ("overweight," PT: $97) views the strong rebound in earnings as a reflection of co's resilient business emphasizing the need to effectively manage investment portfolio risks and sustain earnings stability
** Evercore ISI ("outperform," PT: $108) says consistent underwriting and spread results were reassuring, with revenue growth momentum standing out as a key differentiator for MET vs. peers
** UBS ("buy," PT: $95) says group disability and supplemental lines, which faced margin pressure in H1 2025, will see improvement in Q4 from dental and seasonal trends
(Reporting by Kanishka Ajmera in Bengaluru)
((Kanishka.Ajmera@thomsonreuters.com))